Additional file 2: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Swystun, Veronica; Green, Francis; Dennis, John; Rampakakis, Emmanouil; Lalli, Gurkeet; Fadayomi, Morenike; Chiu, Andrea; Shrestha, Grishma; El Shahat, Sharif; Nelson, David; El Mays, Tamer; Pieron, Cora; Leigh, Richard

doi:10.6084/m9.figshare.6600812.v1

sorry, we can't preview this file

13063_2018_2720_MOESM2_ESM.docx (102.32 kB)

Additional file 2: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

journal contribution

posted on 2018-06-18, 05:00 authored by Veronica Swystun, Francis Green, John Dennis, Emmanouil Rampakakis, Gurkeet Lalli, Morenike Fadayomi, Andrea Chiu, Grishma Shrestha, Sharif El Shahat, David Nelson, Tamer El Mays, Cora Pieron, Richard Leigh

Schedule of assessments during the clinical trial study. (DOCX 102 kb)

Funding

Alberta Innovates - Health Solutions

History

Usage metrics

Keywords

Novel bronchodilator Asthma S1226 Carbon dioxide (CO2)Perflubron Clinical trial

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

sorry, we can't preview this file

Additional file 2: of A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Funding

Alberta Innovates - Health Solutions

History

Usage metrics

Categories

Keywords

Licence

Exports